| Released | Contributor | Author | Title | Pages | Price |
| 28-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD | 5 |
$25 |
| 28-Nov-2009 | Standard & Poor's STARS Report |
N/A
| Dr. Reddy's Labs ADS | 8 |
$35 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | DR REDDY S LABORATORIES INC (RDY=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | DR REDDY S LABORATORIES INC (RDY=US) 12-months forecast | 1 |
$15 |
| 27-Nov-2009 | Validea |
N/A
| Validea Guru Analysis Report for RDY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Dr Reddys Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for RDY | 13 |
$25 |
1.48% Nasdaq 0.00%
Research Reports
